Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 14, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Thyroid Cancer

Interventions

DRUG

Iodine-124

Given Orally

PROCEDURE

Positron Emission Tomography (PET)/Computerized tomography (CT)

Combination of PET and CT imaging

Trial Locations (1)

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors

collaborator

United States Department of Defense

FED

lead

Thomas Hope

OTHER

NCT06961084 - Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer | Biotech Hunter | Biotech Hunter